pain
Navigation Links
pain at medicine technology
Point of Care Cardiac Analyzers Yield Rapid Cardiac Marker Results
...rotocols for diagnosing ACS in patients with chest pain necessitates the reduction of turnaround time (TAT) for cardiac marker results. Recommendations for the optimum TAT vary from 30 to 60 minutes. With regard to TAT, quantitative point of care (POC) assays that directly assay whole blood provide an a...Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
...t (N=103) were acneform rash(76%), asthenia (45%), pain (28%), fever (27%) and weight loss(27%). The most common adverse events seen in patients with mCRCreceiving ERBITUX with irinotecan (n=354) or ERBITUX as a singleagent (n=420) were acneform rash (88%/90%), asthenia/malaise(73%/48%), diarrhea (72%/25......aused a statistically significant reduction in the pain anditching of a rash that results from the use of ...neck, back, hands, and/or legs resulting in severe pain and itchingfor the patient. We know of no other evidence-based topicalapplications reported in the s......complete remission ofactinic lesions. Since strong pain often occurs during photodynamictherapy with competitor products, the appearance of pain during theirradiation after BF-200 ALA application was also monitored. When patients were evaluat......fter completion of surgery when patients reporteda pain intensity score (PI) of at least 2 (moderate pain)...dminister AeroLEF(TM) to treat up to twoadditional pain episodes during the study period. For each painepisode, patients were instructed to continue theself...Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
...er develop thisproduct candidate. Auxilium has two pain products using itstransmucosal film delivery syste... development.Auxilium has rights to six additional pain products and productsfor hormone replacement and urologic disease using its transmucosalfilm deliver...Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
...treatedwith CB7630 also experienced improvement in pain and a reduction inopioid use. Currently 21 of the...reated with CB7630 also experienced improvement in pain and areduction in opioid use. Twenty-eight of the 43 patients (65%)enrolled in this trial are still ......fering from osteoporosis, whichwould alleviate the pain and inconvenience associated with theircurrent treatment, thereby increasing compliance," said Dr. DaphnaHeffetz, CEO of TransPharma Medical Ltd. "Strongly encouraged bythe results of our series of phase I studies, which included atotal of 66 post-me......he (3.8 percent), diarrhea(2.3 percent), abdominal pain (2.3 percent), constipation (2.3percent), and vomiting (1.5 percent). Please see full Prescribing Information for more details. A copyof full Prescribing Information can be obtained by visitingPREZISTA.com. About PREZISTA PREZISTA was developed by......; diarrhea 22% (Grade3/4: 1%); and musculoskeletal pain 20% (Grade 3/4: 3%).Treatment-related hematological adverse events greater than orequal to 20% included: leukopenia 90% (Grade 3/4: 49%); anemia 84%(Grade 3/4: 8%); neutropenia 79% (Grade 3/4: 54%); andthrombocytopenia 44% (Grade 3/4: 8%). About Ixa...Genzyme Announces Results of Clinical Trial of Hylastan
...ificant andclinically meaningful reduction in knee pain compared to baselinefor each of the three treatmen...nt of demonstrating that hylastan providessuperior pain relief to steroids. The safety profile of the threetreatment arms appeared to be comparable in the p...Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
...t 12 weeks, primary symptoms, including lower limb pain andcoldness, were significantly improved in 137 (90.1%) of thepatients; limb ulcers improved or healed in 46 (86.8%) of the 53patients, while 25 of the 48 (47.9%) patients with limb gangreneremained steady or improved. Angiography (an X-ray) beforetr......itis of the knee produced substantialreductions in pain that persisted for up to 12 weeks. "The positive preliminary results from this knee pain studyfurther strengthen our belief that Adlea will prove to be a safeand effective drug in multiple ...Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
... the development and commercialisation ofdrugs for pain control, sedation and other CNS disorders such asParkinson's disease. The company is based in Cambridge, England.For further information visit the CeNeS web site: <a target="_blank" href="http://www.cenes.com/">www.cenes.com About COMT inhi...... A previous study showed that mostpatients achieve pain control using Labopharm's once-daily tramadolat a dose of 200 mg. The data in this poster suggest that, for mostpatients, after starting with a dose of 100 mg for two days, thetherapeutic dose of 200 mg could be achieved after two days withoutincreas...CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and Pain, but Not CRP
.... For CRx-150 treated subjects, median baseline pain as measuredon a visual analogue scale (VAS), went from 63.0mm to 37.0mm at day42, with a median change of -11.5mm, whereas placebo went from64.5mm at baseline to 59.5mm at day 42, with a median change of-2.0mm (p=0.04). CRx-150 was generally well to...... QUADRAMEThave not yet found their place in either pain palliation or diseasemanagement. Accordingly, the ... approved dose of QUADRAMET for palliation of bone pain is1.0 mCi/kg. Patients were enrolled alternately into parallelcohorts. A summary of the poster is a......he most common adverseevent reported was abdominal pain which was typicallymild-to-moderate in severity. ...About Opioid-Induced Constipation Opioids provide pain relief by interacting with specific opioidreceptors located in the central nervous system (CNS) - th......oductivity annually. Currenttreatments address the pain but not the underlying problem.Columbia's hypothes...he severe cramping that results in thedebilitating pain of dysmenorrhea. About Columbia Laboratories Columbia Laboratories, Inc. is a is a specialty pharm......le neurological indications, including neuropathic pain andopioid withdrawal. "The work on this medicatio..., often have modest efficacy incontrolling chronic pain because they are targeted specifically toact on neurons. Additionally, opioid use can lead to depend...ACE-011 Improves Multiple Myeloma Bone Disease in a Preclinical Model
...erience serious clinicalcomplications such as bone pain and fractures", said Matthew L.Sherman, M.D., Chief Medical Officer at Acceleron. "We are excitedby the encouraging results in this preclinical model of multiplemyeloma as we prepare for a phase 2 clinical trial in multiplemyeloma later this year". ......ents treated withJANUVIA was as follows: abdominal pain (JANUVIA 100 mg, 2.3%; placebo,2.1%), nausea (1.4%, 0.6%), and diarrhea (3.0%, 2.3%). No clinically meaningful changes in vital signs or in ECG(including in QTc interval) were observed in patients treated withJANUVIA. Laboratory Tests The in......t, unstable chest pain,revascularization, or chest pain requiring emergencyhospitalization. Major coronary...ould tell their doctors if they feelany new muscle pain or weakness. This could be a sign of rare butserious muscle side effects. Patients should tell their......tions areanalgesics and antidepressants to control pain symptoms. Incontrast, SB-509 is designed to addres...bility ofSB-509 treatment as well as evaluation of pain and clinical effectson lower limb diabetic neuropathy at one, two, three and six monthspost-treatmen......ents treated withJANUVIA was as follows: abdominal pain (JANUVIA 100 mg, 2.3%; placebo,2.1%), nausea (1.4%, 0.6%), and diarrhea (3.0%, 2.3%). No clinically meaningful changes in vital signs or in ECG(including in QTc interval) were observed in patients treated withJANUVIA. Laboratory Tests The in...... deep intra-muscularinjection, with injection site pain and potential irritation andinfection. CRINONE 8% bioadhesive vaginal gel is self-administeredat home once a day using a convenient, patient-friendly, pre-filledapplicator." The full in-press article is available for purchase athttp://www.fertstert....Research on New Treatment for Neglected Disease Published in The New England Journal of Medicine
...safety profile, which included mild injection-site pain in 55% ofpatients and transient increases in liver...onamong patients treated with Paromomycin was mild pain at theinjection site. About Paromomycin IM Injection An off-patent aminoglycoside antibiotic, paro...Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia Clinical Trial
...iting (cethromycin 2.7%, Biaxin(R) 1.5%),abdominal pain (cethromycin 1.5%, Biaxin(R) 3.1%) and tastedisturbance (cethromycin 11.1%, Biaxin(R) 6.2%). No drug-relatedserious adverse events were observed in any study subject. Liverfunction tests and electrocardiogram monitoring demonstrated nosignificant dif...Vical Licensee AnGes MG Announces Positive Results of Phase 3 Angiogenesis Trial in Japan
...ficacy. The primary endpoints, improvement of rest pain ((VAS(Visual Analog Scale)) or ischemic ulcer size...e primary endpoints, which is, improvement of rest pain ((VAS(Visual Analog Scale)) or ischemic ulcer size, at 12 weeks postdosing, showed 30.8% improvement...Javelin Pharmaceuticals Announces Successful Pivotal Phase 3 Trial Data
...ized patientswith moderate to severe post-surgical pain enrolled at 7 sites inthe United States. These patients received either 7.5 mg Rylomineevery hour as needed, 15 mg Rylomine every three hours as needed,7.5 mg IV morphine, or matching placebos. In this "blinded" study,patients received treatments of ...Salix Pharmaceuticals Announces Positive Top Line Results of Balsalazide Tablets Registration Study
...se events most frequently: headache(8%); abdominal pain (6%); diarrhea (5%); nausea (5%); vomiting(4%); respiratory infection (4%); and arthralgia (4%). Withdrawalfrom therapy due to adverse events was comparable to placebo. Salix also markets XIFAXAN(R) (rifaximin) tablets 200 mg ,OSMOPREP(TM) Tablets (......inue to seek treatments that not onlyalleviate the pain and inflammation but also slow diseaseprogression, thereby inhibiting the joint damage that can hinderpatients from performing daily activities. More information on RA and current treatment options can befound at <a target="_blank" href="http://......Cept is focused on unmet needs in the treatment of pain andcancer. EpiCept has a staged portfolio of pharmaceutical productcandidates with several pain therapies in late-stage clinicaltrials, and a lead oncology compound (for acute myeloid leukemia,or ...Solstice Neurosciences Presents Escalating Dose Study at International Congress in Istanbul, Turkey
...tively be used in a variety of CD patients for the pain andabnormal head position associated with this dev...rst FDA-approved neurotoxin indicated for the neck pain andabnormal head position associated with cervical dystonia. Before administering MYOBLOC, physicia......se in certain types of patients withosteoarthritic pain of the knee and hip in more than 50 countries,including the European Union, Canada and Latin America. In the US, this medicine is under review by the Food and DrugAdministration (FDA) for relief of the signs and symptoms ofosteoarthritis. "Evidence......AI of at least 4 and visual analogscale for spinal pain of at least 4, each on a scale of one to 10)were r... spinal arthritis andsymptoms of inflammatory back pain often first present in peoplebefore age 35. It typically begins in the late teens and earlytwenties ......red with 26% of NSAIDpatients) and upper abdominal pain (10% vs. 13%). All other GIevents occurred in less than 10% of patients in both groups. In ananalysis of cardiovascular outcomes in TARGET, the incidence ofevents -- defined as non-fatal and silent myocardial infarction,stroke, or cardiovascular deat...Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid Arthritis Study
...y affectedjoints are the hands and feet. The joint pain of RA can impact apatient's ability to perform normal daily activities, limit jobopportunities, and make family and household responsibilities achallenge. RA afflicts more than 9.7 million peopleworldwide; according to the World Health Organization...Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139 Presented at EULAR
...onder analyses: -- BLISS response of individual pain of less than or equal to 20(27% CRx-102 vs. 6% placebo, p=0.035) -- Modified OMERACT-OARSI response (50% CRx-102 vs. 30% placebo,p=NSS) -- AUSCAN 20/50/70 (AUSCAN 70: 23% CRx-102 vs. 3% placebo,p=0.037) In a satellite symposium presentation, Dr. J...Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid Arthritis
...imed at controlling disease progression, providing pain relief and reducing swelling,preventing joint damage and deformity and maintaining function ofthe affected joints to prevent disability. Traditional treatments for RA include nonsteroidalanti-Inflammatory drugs (NSAIDs), corticosteroids and diseasem......es have JRA.Symptoms of JRA include fatigue, joint pain and stiffness followingsleep or inactivity, fever and associated muscle weakness. Thereare differing presentations of the signs and symptoms of JRA andthere is no specific test for diagnosis. "Early diagnosis and treatment are crucial to managing ......dZYFLO are sinusitis, nausea and pharyngolaryngeal pain andabdominal pain, upset stomach and nausea, respectively. For full prescribing information for ZYFLO CR, please visitwww.zyflocr.com or call the Company's toll free telephone number1-866-835-8216 to request medical information. For full prescribin......lex dose reduces both the duration andintensity of pain more effectively than 12.5mg or 25mg and issignifi...0012) than Lucrin in reducing thenumber of days of pain over the course of the study. Pain reductionalso occurred more rapidly than with the active control,...... help repair the injured tissue and reduce related pain andinflammation. The Company's Electroceuticals(TM...wide array of conditions, includingchronic wounds, pain and edema following plastic and reconstructivesurgery and chronic inflammatory disorders. Forward-L...Gabapentin Shown Effective for Fibromyalgia Pain
...of seizures, can be an effective treatment for the pain andother symptoms associated with the common, often hard-to-treatchronic pain disorder, fibromyalgia. In the NIAMS-sponsored, randomized, double-blind clinical trialof 150 women......t withFROVA prevented or significantly reduced the pain ofdifficult-to-treat but often predictable migrain...hysicians who need to realize that thedebilitating pain of menstrual migraine is not inevitable and isnot a normal part of their menstrual cycle." "In pati...Studies Show Efficacy and Safety of Alexion's Soliris in Broad Population of PNH Patients
...were headache, nasopharyngitis(a runny nose), back pain and nausea.(14) Treatment with Solirisshould not alter anticoagulant management because the effect ofwithdrawal of anticoagulant therapy during Soliris treatment hasnot been established. The U.S. product label for Soliris also includes a boxedwarnin...Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free Response Across Multiple Attacks
...in daily activities. Most migraine studiesfocus on pain relief or pain-freedom, which only assesses headpa...tis, bursitis, acutegout and for the management of pain and primary dysmenorrhea.Naproxen-containing products should not be used by patients whohave had all...ProEthic Pharmaceuticals Presents Positive Data for PRO-513 at American Headache Society Meeting
...nter. Thefindings showed that PRO-513 relieved the pain of migraine forpatients within 30 minutes, reduced...l that enrolled 690 adultpatients. The two-hour pain free response among patients, the primaryefficacy endpoint of the trial, was 25 percent in the PRO-5...Trial Results with Intranasal Fentanyl Hold Promise for Treatment of Breakthrough Pain in Cancer
...class novelformulation could provide fast onset of pain relief and shortduration of effect, mirroring the breakthrough pain oftenexperienced by patients with cancer. The majority of patients with cancer experience chronic p......uct profile and showedthat M6G provided equivalent pain relief to morphine but inducedsignificantly less p...w that M6G is equivalent to morphinein controlling pain but has a superior side-effect profile. Thisshould give clinicians more confidence that patients are......patients with diabetic peripheralneuropathic (DPN) pain treated with the investigational drugZenvia(TM) (d...Congress on Neuropathic Pain (ICNP) in Berlin. DPN pain is a common complication of diabetes that hassignificant impact on outcomes of concern to patients i...To Stent or Not: Is That the Question?
...what they do. Still, patients whoexperience angina pain despite medical therapy may elect to haveangioplasty to reduce chest pain -- just as one third of thepatients in the study did. "It's unfortunate the press and public misund......n ofNGX-4010, the Company's novel dermal patch, on pain due to PHN. Theprimary endpoint in this Phase 3 tr...onstratinga statistically significant reduction in pain over an 8-week period(NGX-4010, -29.6% vs. control, -19.9%; p = 0.001). The reduction ofpain was sus...Nasalfent shows clinically meaningful pain relief within 5minutes of dosing and is well-toler...meaningful levels ofpain relief and a reduction in pain intensity within 5 minutes ofdosing. The open-label, multi-centre study, was conducted in two parts......ceptor antagonist, significantly improved migraine pain relieftwo hours after dosing compared to placebo, ...these receptors andfacilitates the transmission of pain impulses. MK-0974 blocks thebinding of CGRP to receptors within these areas and thereby isbelieved t...XTL Provides Update on Phase I Clinical Trial of XTL-2125
...on of therapeutics forthe treatment of neuropathic pain and hepatitis C. XTL isdeveloping Bicifadine, a serotonin and norepinephrine reuptakeinhibitor, for the treatment of neuropathic pain. XTL is alsodeveloping several novel pre-clinical hepatitis C small moleculeinhibitors. XTL also has an active in-li...Roxro Pharma’s Novel Intranasal Pain Reliever Effective, Well Tolerated in Phase 3 Study
...intranasalanalgesic, rapidly and effectively eased pain and was welltolerated by patients who had undergon...ho received ROX-888 reportedgreater improvement in pain relief and required 22 percent lessmorphine in the first 24 hours following surgery compared topatie...Extensive Clinical Data on Erbitux Presented at the 2007 ASCO Annual Meeting
...t (N=103) were acneform rash(76%), asthenia (45%), pain (28%), fever (27%) and weight loss(27%). The most common adverse events seen in patients with mCRCreceiving ERBITUX with irinotecan (n=354) or ERBITUX as a singleagent (n=420) were acneform rash (88%/90%), asthenia/malaise(73%/48%), diarrhea (72%/25...... was seen in 10 of the 15symptom scales, including pain (p<0.0001), nausea (p<0.0001)and global health status (p=0.047). “The first set of data from the EPIC trial demonstratedthat progression-free survival and tumor shrinkage increasedsignificantly when Erbitux was administered to this pat...Other ContentsabnormalitiesabnormalitiesabnormalitiesabnormalitiesabnormalitiesabnormalitiesabnormalitiesabnormalitiespolishpolishnailnailnailnailnailpolypspolypspolypsnauseanauseanauseanauseanaturopathyOther TagsMillerMillerFundsFundsAppletonImagesImagesEskerOther Tagsformula 2formula 3formula 4happiness 2happiness 3compelling 2compelling 3compelling 4know 2know 3know 4know 5know 6know 7know 8know 9know 10pizza 2potentially 2potentially 3potentially 4potentially 5potentially 6potentially 7potentially 8potentially 9potentially 10regional 2regional 3regional 4regional 5
(Date:5/16/2008)... at the National Institute of Standards and Techno... batches of carbon nanotubes by length using high-... carbon nanotubes depend on the lengths of these m...t features of the new technique, say the scientist... industrial quantities of high-quality nanotubes. ...
(Date:5/16/2008)..., 2008 Changing the sugars attached to a hormone ...y levels in mice nearly 50 percent, a research gro...St. Louis has found. The change appears to alter a...ntricate regulatory system that may one day be use...he right amount of key reproductive hormones such ...
(Date:5/16/2008)... A new study reveals the genetic identity of human...ible for sexual transmission, in unprecedented det...he ongoing search for an effective HIV/AIDS vaccin...t Birmingham (UAB). The UAB team found that among ... transmission. , Earlier studies have shown that...
(Date:5/16/2008)... in maintaining germ-free homes for their children...id adoption of anti-bacterial soaps and cleaning a...tic soaps now have come under scrutiny by the EPA ...h concerns. , Two closely related antimicrobia...of the debacle. Whereas triclosan (TCS) has long c...
Breaking Biology News(10 mins):Spin control: New technique sorts nanotubes by length 2Disabling mouse enzyme increases fertility 2HIV infection stems from few viruses 2New study links fate of personal care products to environmental pollution and human health concerns 2New study links fate of personal care products to environmental pollution and human health concerns 3Zinc Helps Elderly Ward Off Pneumonia 4901 1Zinc Helps Elderly Ward Off Pneumonia 4901 2Accuray Announces Four New Products at Nations Leading Radiation Oncology Meeting 4898 1Accuray Announces Four New Products at Nations Leading Radiation Oncology Meeting 4898 2Accuray Announces Four New Products at Nations Leading Radiation Oncology Meeting 4898 3Accuray Announces Four New Products at Nations Leading Radiation Oncology Meeting 4898 4Accuray Announces Four New Products at Nations Leading Radiation Oncology Meeting 4898 5Coalition for Pulmonary Fibrosis Fundraising Events Raise 24280 000 for IPF 4895 1Coalition for Pulmonary Fibrosis Fundraising Events Raise 24280 000 for IPF 4895 2Coalition for Pulmonary Fibrosis Fundraising Events Raise 24280 000 for IPF 4895 3Highmark Blue Cross Blue Shield Products Ranked Among Americas Best Health Plans 28R 29 4892 1Highmark Blue Cross Blue Shield Products Ranked Among Americas Best Health Plans 28R 29 4892 2(Date:5/16/2008)...n Society of Clinical Oncology meeting in Chicago ... about 25 percent of patients with colon cancer an...orectal cancers will be staged. , This new stu...ulation-based statistic registries from 1992 to 20...outcomes of patients with positive nodes (Stage II...
(Date:5/16/2008)...ewswire/- "Huh, what did you,say?" is a phrase bei...children. More than 30 million Americans, that is ...and the numbers are growing at a dramatic rate.,Th...ome form of hearing,loss. An effort to bring more ...hat led Kathlyn Maguire, who has profound hearing ...
(Date:5/16/2008)... HIV Vaccine Awareness Day, May,18, WASHINGTON, M...into the,AIDS epidemic, someone is newly infected ...ay 18, HIV Vaccine Awareness Day, AIDS Action, one...te of Allergy and Infectious,Disease (NIAID) HIV V...ne,to help end the AIDS epidemic by participating ...
(Date:5/16/2008)...e/ -- As tropical storms,continue to batter the af...yclone Nargis are vulnerable to diseases and other...ance, as exposure to the foul weather and,malnutri... "The people living in these conditions urgently ...et back on their feet," said David Meltzer,senior...
Breaking Medicine News(10 mins):Health News:Huh, What Did You Say?: May is 'Better Hearing and Speech Month' 2Health News:Huh, What Did You Say?: May is 'Better Hearing and Speech Month' 3Health News:AIDS Action Urges Everyone to Help End the AIDS Epidemic by Being Part of the Search for an HIV Vaccine 2Health News:Myanmar Cyclone Survivors Face New Challenges 2[0] New method proposed for determining which patients should get treatment for colorectal cancer[0] Huh, What Did You Say?: May is 'Better Hearing and Speech Month'[0] AIDS Action Urges Everyone to Help End the AIDS Epidemic by Being Part of the Search for an HIV Vaccine[0] Myanmar Cyclone Survivors Face New Challenges
| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |